Cargando…
How much survival benefit is necessary for breast cancer patients to opt for adjuvant chemotherapy? Results from a Chilean survey
BACKGROUND: Breast cancer (BC) is the leading cause of cancer death in Chilean women. Adjuvant chemotherapy decreases recurrence and death from BC. The recommendation to indicate chemotherapy is complex. Adjuvant! Online is a valuable computational tool to predict survival benefit obtained with adju...
Autores principales: | Acevedo, Francisco, Sanchez, Cesar, Jans, Jaime, Rivera, Solange, Camus, Mauricio, Besa, Pelayo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905782/ https://www.ncbi.nlm.nih.gov/pubmed/24678346 http://dx.doi.org/10.3332/ecancer.2014.391 |
Ejemplares similares
-
Breast cancer and pregnancy: a comparative analysis of a Chilean cohort
por: Sánchez, César, et al.
Publicado: (2014) -
Foot orthoses: how much customisation is necessary?
por: Menz, Hylton B
Publicado: (2009) -
Is adjuvant chemotherapy necessary for early gastric cancer?
por: Mei, Yu, et al.
Publicado: (2022) -
Is adjuvant chemotherapy necessary in older patients with breast cancer?
por: Morita, Midori, et al.
Publicado: (2022) -
Pathological complete response to neoadjuvant chemotherapy, but not the addition of carboplatin, is associated with improved survival in Chilean triple negative breast cancer patients: a report of real world data
por: Walbaum, Benjamín, et al.
Publicado: (2021)